Treatment of hepatocellular carcinoma with child-Pugh C cirrhosis

Oncology (Switzerland)

Volumn 87, Issue , 2014, Pages 99-103

  Nouso, Kazuhiro ^a   Kokudo, Norihiro ^b   Tanaka, Masatoshi ^c   Kuromatsu, Ryoko ^d   Nishikawa, Hiroki ^e   Toyoda, Hidenori ^f   Oishi, Naoki ^g   Kuwaki, Kenji ^a   Kusanaga, Masashi ^h   Sakaguchi, Takuki ⁱ   Morise, Zenichi ^j   Kitai, Satoshi ^k   Kudo, Masatoshi ^k  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Department of Neurosurgery   (Japan)

^d KURUME UNIVERSITY   (Japan)

^e OSAKA RED CROSS HOSPITAL   (Japan)

^f OGAKI MUNICIPAL HOSPITAL   (Japan)

^g KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^h Yame General Hospital   (Japan)

ⁱ HIROSHIMA CITY HOSPITAL   (Japan)

^j FUJITA HEALTH UNIVERSITY   (Japan)

^k KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Child Pugh C cirrhosis; Hepatocellular carcinoma; Liver transplantation

Indexed keywords

CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CONFERENCE PAPER; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RUPTURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CLINICAL PRACTICE; COMPLICATION; HEPATIC ARTERY; JAPAN; LIVER NEOPLASMS; PATHOLOGY; QUESTIONNAIRE; REGIONAL PERFUSION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HEPATIC ARTERY; HUMANS; JAPAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84922481443     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000368152     Document Type: Conference Paper

References (23)

1. Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, Okusaka T, Miyayama S, Tsuchiya K, Ueshima K, Hiraoka A, Ikeda M, Ogasawara S, Yamashita T, Minami T, Yamakado K; Liver Cancer Study Group of Japan: JSH consensus-based clinical practice guideline for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan. Liver Cancer 2014;3:458-468.
2. Bruix J, Sherman M; American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1020-1022.
3. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepat 2012; 56: 908-943.
4. Belghiti J, Fuks D: Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer 2012; 1: 71-82.
5. YL Cheah, PK Chow: Liver transplantation for hepatocellular carcinoma: An appraisal of current controversies. Liver Cancer 2012; 1: 183-189.
6. Chan SC, Sharr WW, Chan AC, Chok KS, Lo CM: Rescue living-donor liver transplantation for liver failure following hepatectomy for hepatocellular carcinoma. Liver Cancer 2013; 2: 332-337.
7. Chan SC: Liver transplantation for hepatocellular carcinoma. Liver Cancer 2013; 2: 338-344.
8. Akamatsu N, Sugawara Y, Kokudo N: Living donor liver transplantation for patients with hepatocellular carcinoma. Liver Cancer 2014; 3: 108-118.
9. Kokudo N, Makuuchi M: Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 2009; 44(suppl 19): 119-121.
10. Lin SM: Local ablation for hepatocellular carcinoma in Taiwan. Liver Cancer 2013; 2: 73-83.
11. Lencioni R: Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer 2012; 1: 41-50.
12. Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Jin GY, Lee JM: Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety. AJR Am J Roentgenol 2006; 186:S261-S268.
13. Kudo M, Osaki Y, Matsunaga T, Kasugai H, Oka H, Seki T: Hepatocellular carcinoma in Child-Pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments. Dig Dis 2013; 31: 490-498.
14. Morise Z, Kawabe N, Kawase J, Tomishige H, Nagata H, Ohshima H, Arakawa S, Yoshida R, Isetani M: Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease. World J Hepatol 2013; 5: 487-495.
15. Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, Yoshida R, Isetani M: Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 2014, in press.
16. Nakanishi S, Michitaka K, Miyake T, Hidaka S, Yoshino I, Konishi I, Iuchi H, Horiike N, Onji M: Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma. Intern Med 2003; 42: 416-420.
17. Nishikawa H, Kita R, Kimura T, Ohara Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y: Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosis. Anticancer Res 2014; 34: 3039-3044.
18. Nouso K, Ito Y, Kuwaki K, Kobayashi Y, Nakamura S, Ohashi Y, Yamamoto K: Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. Br J Cancer 2008; 98: 1161-1165.
19. Wakuta A, Nouso K, Kariyama K, Nishimura M, Kishida M, Wada N, Mizushima T, Higashi T, Tanimoto M: Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis. Oncology 2011; 81: 39-44.
20. Kudo M: Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy. Liver Cancer 2012; 1: 62-70.
21. Gumbs AA, Gayet B: Adopting Gayet's techniques of totally laparoscopic liver surgery in the United States. Liver Cancer 2013; 2: 5-15.
22. Hwang DW, Han HS, Yoon YS, Cho JY: Laparoscopic liver resection for hepatocellular carcinoma: Korean experiences. Liver Cancer 2013; 2: 25-30.
23. Peck-Radosavljevic M: Drug therapy for advanced-stage liver cancer. Liver Cancer 2014; 3: 125-131.